InvestorsHub Logo
Followers 0
Posts 41
Boards Moderated 0
Alias Born 11/06/2018

Re: VictorMasonIsRight post# 73

Monday, 12/10/2018 6:05:09 PM

Monday, December 10, 2018 6:05:09 PM

Post# of 512
Looking forward to see what tomorrow’s ACNP presentation will do to RLMD's exposure. Mason, your $15-$30/share prediction by July ’19 would certainly be acceptable. :)
What estimated market cap and shares outstanding are you using to predict that? How many warrants are out there to consider for dilution to add to the current @25M shares? I read that Allergan paid @$571 million upfront plus backend payments (to over 1B) to acquire Naurex’s rapastinel, (IV admin, less desired of course) a few years back. Just curious…Thanks for your posts.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RLMD News